We report the case of a 78-year-old man diagnosed with metastatic renal cell carcinoma developping acute haemolysis under Sunitinib as well as under Sorafenib. This side effect induced a definitive withdrawal from the drugs. As these drugs are used more widely, rare side effects are bound to appear.
|Number of pages||3|
|Journal||Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg|
|Publication status||Published - 2009|